Next Article in Journal
Reevaluation of the Acute Cystitis Symptom Score, a Self-Reporting Questionnaire. Part I. Development, Diagnosis and Differential Diagnosis
Next Article in Special Issue
Fragment-Based Discovery of Inhibitors of the Bacterial DnaG-SSB Interaction
Previous Article in Journal / Special Issue
Establishing a System for Testing Replication Inhibition of the Vibrio cholerae Secondary Chromosome in Escherichia coli
Article Menu

Export Article

Open AccessArticle
Antibiotics 2018, 7(1), 5; https://doi.org/10.3390/antibiotics7010005

Screening of E. coli β-clamp Inhibitors Revealed that Few Inhibit Helicobacter pylori More Effectively: Structural and Functional Characterization

1
School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India
2
Department of Bioscience and Biotechnology, Banasthali University, Rajasthan 304022, India
3
Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110067, India
4
Department of Microbiology, Central University of Rajasthan, Kishangarh 305801, India
*
Author to whom correspondence should be addressed.
Received: 10 November 2017 / Revised: 9 January 2018 / Accepted: 10 January 2018 / Published: 11 January 2018
(This article belongs to the Special Issue Bacterial DNA Replication and Replication Inhibitors)
Full-Text   |   PDF [3590 KB, uploaded 11 January 2018]   |  

Abstract

The characteristic of interaction with various enzymes and processivity-promoting nature during DNA replication makes β-clamp an important drug target. Helicobacter pylori (H. pylori) have several unique features in DNA replication machinery that makes it different from other microorganisms. To find out whether difference in DNA replication proteins behavior accounts for any difference in drug response when compared to E. coli, in the present study, we have tested E. coli β-clamp inhibitor molecules against H. pylori β-clamp. Various approaches were used to test the binding of inhibitors to H. pylori β-clamp including docking, surface competition assay, complex structure determination, as well as antimicrobial assay. Out of five shortlisted inhibitor molecules on the basis of docking score, three molecules, 5-chloroisatin, carprofen, and 3,4-difluorobenzamide were co-crystallized with H. pylori β-clamp and the structures show that they bind at the protein-protein interaction site as expected. In vivo studies showed only two molecules, 5-chloroisatin, and 3,4-difluorobenzamide inhibited the growth of the pylori with MIC values in micro molar range, which is better than the inhibitory effect of the same drugs on E. coli. Therefore, the evaluation of such drugs against H. pylori may explore the possibility to use to generate species-specific pharmacophore for development of new drugs against H. pylori. View Full-Text
Keywords: DNA replication; surface competition assay; β-clamp; E. coli inhibitors; structure; screening DNA replication; surface competition assay; β-clamp; E. coli inhibitors; structure; screening
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Pandey, P.; Verma, V.; Dhar, S.K.; Gourinath, S. Screening of E. coli β-clamp Inhibitors Revealed that Few Inhibit Helicobacter pylori More Effectively: Structural and Functional Characterization. Antibiotics 2018, 7, 5.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top